Leerink Partners Maintains Outperform on Merck & Co, Raises Price Target to $161

Benzinga · 1d ago
Leerink Partners analyst Daina Graybosch maintains Merck & Co (NYSE:MRK) with a Outperform and raises the price target from $127 to $161.